Send Inquiry

Request To Call Back

BD- DAPTO 350 INJ

Name: BD- DAPTO 350 INJ
Brand: Shivsrushti Surgimed Private Limited
Price: 2079.0 INR
Availability: InStock

Price 2079.0 INR/ Piece

Get a Price/Quote

MOQ : 50 Pieces

BD- DAPTO 350 INJ Specification

Brand Name
BD- DAPTO 350 INJ

Ingredients
Product Name: BD-DAPTO 350 Injection Generic Name: Daptomycin for Injection Strength: 350 mg Brand: BDR Dosage Form: Lyophilized Powder for Injection Route of Administration: Intravenous (IV) Packaging: Single vial Product Description: BD-DAPTO 350 Injection contains Daptomycin 350 mg, a cyclic lipopeptide antibiotic used for the treatment of serious bacterial infections caused by Gram-positive organisms. It is particularly effective against complicated skin and soft tissue infections, bacteremia, and right-sided infective endocarditis caused by susceptible strains. Daptomycin works by disrupting bacterial cell membrane function, leading to rapid depolarization, inhibition of protein, DNA, and RNA synthesis, and bacterial cell death. It is administered intravenously under strict medical supervision in hospital settings. Key Features: Potent Gram-positive antibacterial activity Effective against MRSA and other resistant strains Rapid bactericidal action Suitable for hospital and institutional use Manufactured under high-quality pharmaceutical standards Indications: Complicated skin and skin structure infections (cSSSI) Staphylococcus aureus bacteremia Right-sided infective endocarditis Other serious Gram-positive infections Storage: Store below 25 C. Protect from light and moisture. Manufacturer: BDR Pharmaceuticals International Pvt. Ltd. Supply: Available for hospital, institutional, bulk, and export supply.

Quantity
50 Pieces

BD- DAPTO 350 INJ Trade Information

Minimum Order Quantity
50 Pieces

Supply Ability
1000 Pieces Per Month

Delivery Time
7 Days

About BD- DAPTO 350 INJ

Product Name: BD-DAPTO 350 Injection
Generic Name: Daptomycin for Injection
Strength: 350 mg
Brand: BDR
Dosage Form: Lyophilized Powder for Injection
Route of Administration: Intravenous (IV)
Packaging: Single vial

Product Description:

BD-DAPTO 350 Injection contains Daptomycin 350 mg, a cyclic lipopeptide antibiotic used for the treatment of serious bacterial infections caused by Gram-positive organisms. It is particularly effective against complicated skin and soft tissue infections, bacteremia, and right-sided infective endocarditis caused by susceptible strains.

Daptomycin works by disrupting bacterial cell membrane function, leading to rapid depolarization, inhibition of protein, DNA, and RNA synthesis, and bacterial cell death. It is administered intravenously under strict medical supervision in hospital settings.

Key Features:

Potent Gram-positive antibacterial activity

Effective against MRSA and other resistant strains

Rapid bactericidal action

Suitable for hospital and institutional use

Manufactured under high-quality pharmaceutical standards

Indications:

Complicated skin and skin structure infections (cSSSI)

Staphylococcus aureus bacteremia

Right-sided infective endocarditis

Other serious Gram-positive infections

Storage:

Store below 25C. Protect from light and moisture.

Manufacturer:

BDR Pharmaceuticals International Pvt. Ltd.

Supply:

Available for hospital, institutional, bulk, and export supply.

Powerful Antibiotic Action for Serious Infections

BD-DAPTO 350 Injection is specifically crafted to combat severe bacterial infections caused by Gram-positive organisms, including those from resistant strains like MRSA. Its broad spectrum and potent action make it indispensable in hospitals for conditions where prompt and effective intervention is necessary. The product is manufactured in alignment with international pharmaceutical standards.

Intravenous Delivery for Optimal Efficacy

Administered intravenously, BD-DAPTO 350 ensures rapid entry into the bloodstream, allowing for swift and targeted bacterial eradication. The lyophilized powder format ensures product stability and makes reconstitution easy in clinical environments. This method is strictly managed by healthcare professionals to maximize benefits and minimize risks.

Key Uses and Indications

BD-DAPTO 350 is indicated for treating complicated skin and skin structure infections, Staphylococcus aureus bacteremia, right-sided infective endocarditis, and other serious Gram-positive bacterial infections. Its efficacy against difficult-to-treat and resistant infections supports its role as a critical therapy in hospitals and other healthcare institutions.

FAQ's of BD- DAPTO 350 INJ:

Q: How should BD-DAPTO 350 Injection be administered?

A: BD-DAPTO 350 Injection is administered intravenously, typically by a healthcare professional in a hospital or institutional setting. The lyophilized powder must be reconstituted and prepared under sterile conditions for each dose.

Q: What infections can be treated with BD-DAPTO 350 Injection?

A: This medication is used to treat serious Gram-positive bacterial infections, including complicated skin and skin structure infections, Staphylococcus aureus bacteremia, and right-sided infective endocarditis, especially those caused by resistant organisms such as MRSA.

Q: When is BD-DAPTO 350 Injection typically recommended?

A: BD-DAPTO 350 is recommended when treatment for serious or complicated infections caused by susceptible Gram-positive bacteria is required, particularly in hospital or institutional care where rapid and potent antibiotic action is necessary.

Q: What are the main benefits of using BD-DAPTO 350 Injection for bacterial infections?

A: The main benefits include potent activity against a wide range of Gram-positive bacteria, including antibiotic-resistant strains, rapid bactericidal action, and suitability for severe infections that require hospital-based management.

Q: Where should BD-DAPTO 350 Injection be stored before use?

A: The product should be stored below 25C, away from light and moisture, to maintain stability and efficacy until preparation and use.

Q: What is the process for preparing BD-DAPTO 350 Injection for administration?

A: The lyophilized powder is reconstituted with a suitable sterile solvent by healthcare professionals following standard protocols before IV administration.

Tell us about your requirement

Price:

Quantity

Select Unit

50
100
200
250
500
1000+

Additional detail

Mobile number

More Products in IV Fluids Category

CISATRACIL 10ML INJECTION

Price 405.0 INR / Strip

Minimum Order Quantity : 50 Boxes

Quantity : 50 Boxes

Physical Form : Liquid

Drug Type : Injection

Ingredients : CISARTACIL 10ml Injection Cisatracurium Besylate Injection USP 20mg Brand Name: CISARTACIL 10ml Generic Name: Cisatracurium Besylate Injection USP Strength: 20 mg / 10 ml Dosage Form: Injection Manufacturer: Neon Laboratories Limited Packaging: Standard company packing Product Description: CISARTACIL 10ml Injection contains Cisatracurium Besylate, a nondepolarizing neuromuscular blocking agent used as an adjunct to general anesthesia. It is indicated for facilitating endotracheal intubation and providing skeletal muscle relaxation during surgical procedures and intensive care ventilation. Cisatracurium is known for its predictable onset and intermediate duration of action, making it suitable for controlled muscle relaxation in operation theatres and ICU settings. Common Uses: Facilitation of endotracheal intubation Muscle relaxation during surgeries ICU mechanical ventilation support Adjunct to general anesthesia Key Features: Stable and reliable neuromuscular blockade Intermediate duration of action Suitable for hospital and institutional supply Manufactured under stringent GMP quality standards Note: To be administered only by qualified anesthesiologists or trained healthcare professionals.

Get a Price/Quote

VANKING 1000/1GM

Price 141.0 INR / Piece

Minimum Order Quantity : 50 Units

Quantity : 50 Unit

Physical Form : Liquid

Drug Type : Injection

Ingredients : Product Name: Vanking Injection 1gm (Vancomycin Hydrochloride IP 1000mg)Product Description:Shivsrushti Surgimed Private Limited supplies hospitalgrade Vanking Injection 1gm, designed to ensure optimal patient safety and clinical efficiency. Manufactured using medicalgrade material, this product offers superior durability, sterile integrity, and anatomical comfort. It meets stringent medical guidelines, reducing the risk of healthcareassociated infections. Ideal for operating theatres, diagnostics, and routine ward applications.Key Features:Nontoxic, biocompatible, and completely safe for medical use.Ergonomic design enables precise and hasslefree handling.Ethylene Oxide (EO) sterilized to ensure zero microbial contamination.Highly reliable performance under demanding surgical conditions.Product Specifications:Composition / Active Ingredient: Vancomycin Hydrochloride IP equivalent to Vancomycin 1000 mgForm / Physical State: Sterile Dry Powder for Intravenous (IV) InfusionDiluent: Supplied Without Diluent (Vial Only)Manufacturer / Brand: Neon Laboratories LimitedPackaging Size: Single Vial BoxClinical Indications: Effective for MethicillinResistant Staphylococcus Aureus (MRSA) infections, bacterial septicemia, endocarditis, osteomyelitis, and critical Central Nervous System (CNS) infections.Storage Temperature: Store below 25 C. Do not freeze. Protect from direct light and moisture.Why Source From Shivsrushti Surgimed?We offer an extensive portfolio of highutility healthcare consumables. Our team ensures rigorous quality checks, highly competitive wholesale pricing, and timely order fulfillment for medical distributors and hospitals.Commercial Details:Minimum Order Quantity (MOQ): 50 UnitsSupply Ability: Reliable scale to fulfill large healthcare tenders.Delivery: Shipped safely via reliable logistic networks from our warehouse.

Get a Price/Quote

BDCOLIST 1MIU

Price 97.2 INR / Vial

Minimum Order Quantity : 50 Pieces

Quantity : 50 Pieces

Physical Form : Liquid

Drug Type : Injection

Ingredients : Product Name: BD Colist 1 MIU Injection Brand: BDCOLIST 1 MIU Vial Active Ingredient / Content: Colistimethate Sodium Injection (1 Million IU) Manufacturer / Company: BDR Pharmaceuticals Product Description BDCOLIST 1 MIU Vial is a sterile injectable antibiotic formulation containing Colistimethate Sodium, supplied as a single dose vial of 1 Million International Units (IU). It is indicated for the treatment of serious bacterial infections, especially those due to susceptible Gram negative organisms where other antibiotics are inadequate or ineffective. The product must be used only on the prescription of a qualified healthcare professional and is typically administered by intravenous infusion under clinical supervision. Key Features Composition: Colistimethate Sodium 1 MIU per vial (antibacterial agent) Form: Injectable solution after reconstitution; parenteral use only. Packaging: Single vial packaging. Storage: Store in a cool and dry place as directed by the manufacturer. Prescription Status: Schedule H prescription drug must be dispensed and administered only on medical prescription. Typical Uses (General to Colistimethate Injections) (This reflects standard clinical use for colistimethate sodium injections and is similar across branded products.) Treatment of severe hospital acquired or ventilator associated infections due to Gram negative bacteria when other antibiotics are ineffective. Management of complicated urinary tract infections, bloodstream infections, and pneumonia caused by multidrug resistant strains. Administered under hospital supervision with appropriate dosing and monitoring. Important Notes Colistimethate Sodium is a polymyxin class antibiotic that works by disrupting the bacterial cell membrane, leading to bacterial cell death. Dosing and duration of therapy must be determined by a clinician based on infection severity and patient factors. Use may require monitoring for possible kidney related side effects and other adverse reactions in susceptible patients.

Get a Price/Quote

LIN IV 300ML

Price 77.28 INR / Bottle

Minimum Order Quantity : 100 Bottles

Physical Form : Liquid

Drug Type : Injection

Get a Price/Quote